A COMPARISON OF PROSPECTIVE OUTCOMES OF INFINITY TOTAL ANKLE ARTHROPLASTY VERSUS ANKLE FUSION

Introduction: Ankle fusion (AF) or Total ankle arthroplasty (TAA) can be used to treat end stage ankle arthritis (ESAA). TAA has become more reliable in modern generations with patient specific instrumentation, improvement in polyethylene and ingrowth surfaces. The INFINITY® Total Ankle System (Stryker Inc.) is a 2-component fixed-bearing, bone-sparing modern design introduced in 2014. The purpose of this study is to compare prospective outcomes of Infinity ankles (outcome scores and revision rates) with ankle fusion. Method: 100 patients with prospectively collected data having an INFINITY® TAA between 2013- August 1st, 2021, were compared with 200 ankle fusion patients from 2008 -August 1st, 2021 with a minimum 1 year follow up. The primary outcome was the Ankle Osteoarthritis Scale (AOS). Secondary outcomes were the MODEMS, and SF-36 scores. The average was 5.1 years, and the follow up was 5.9 years for AF and 3.4 years for TAA. Results: Ankle Fusion AOS scores improved from a preoperative average of 55.25±19.31, to 26.01±21.64. TAA scores improved from 52.37±19.09 to 22.33±21.41 for TAA. At the last follow up after surgery (LFU), mean AOS scores in the Infinity cohort were significantly lower after linear regression for baseline variables with a mean difference of −6.76 (−12.52, −0.99 95% CI) p-value 0.02. The difference remained significant after removing 1-year follow up, and 9–14 year follow up, at −6.58 (−12.89, −0.27 95% CI), p-value 0.041. The revision rate for ankle fusion was 3.5%, while revision rate for INFINITY® TAA was 2%. Conclusion: Patients undergoing INFINITY® TAA had significantly lower mean AOS scores than patients undergoing ankle fusion at their last follow up after surgery, both before and after linear regression for baseline variables. This remained significant after excluding earlier (1-year) follow up, and later (9-14 year) follow up for the fusion cohort data. Modern ankle replacement designs continue to improve compared against the ankle fusion gold standard.

Authors

Institutions

Publication Details

Journal
Orthopaedic Proceedings
Published
2025-12-19
DOI
https://doi.org/10.1302/1358-992x.2025.17.008
Primary Topic
Foot and Ankle Surgery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A COMPARISON OF PROSPECTIVE OUTCOMES OF INFINITY TOTAL ANKLE ARTHROPLASTY VERSUS ANKLE FUSION

Oliver Gagné, Kevin Wing, Alastair S. E. Younger, Hubert Wong et al.
Orthopaedic Proceedings
Foot and Ankle Surgery
article

A COMPARISON OF PROSPECTIVE OUTCOMES OF INFINITY TOTAL ANKLE ARTHROPLASTY VERSUS ANKLE FUSION

Oliver Gagné, Kevin Wing, Alastair S. E. Younger, Hubert Wong, Andrea Veljkovic, Murray Penne, J. H. STEYN, Hong Qion
article en

Abstract

Introduction: Ankle fusion (AF) or Total ankle arthroplasty (TAA) can be used to treat end stage ankle arthritis (ESAA). TAA has become more reliable in modern generations with patient specific instrumentation, improvement in polyethylene and ingrowth surfaces. The INFINITY® Total Ankle System (Stryker Inc.) is a 2-component fixed-bearing, bone-sparing modern design introduced in 2014. The purpose of this study is to compare prospective outcomes of Infinity ankles (outcome scores and revision rates) with ankle fusion. Method: 100 patients with prospectively collected data having an INFINITY® TAA between 2013- August 1st, 2021, were compared with 200 ankle fusion patients from 2008 -August 1st, 2021 with a minimum 1 year follow up. The primary outcome was the Ankle Osteoarthritis Scale (AOS). Secondary outcomes were the MODEMS, and SF-36 scores. The average was 5.1 years, and the follow up was 5.9 years for AF and 3.4 years for TAA. Results: Ankle Fusion AOS scores improved from a preoperative average of 55.25±19.31, to 26.01±21.64. TAA scores improved from 52.37±19.09 to 22.33±21.41 for TAA. At the last follow up after surgery (LFU), mean AOS scores in the Infinity cohort were significantly lower after linear regression for baseline variables with a mean difference of −6.76 (−12.52, −0.99 95% CI) p-value 0.02. The difference remained significant after removing 1-year follow up, and 9–14 year follow up, at −6.58 (−12.89, −0.27 95% CI), p-value 0.041. The revision rate for ankle fusion was 3.5%, while revision rate for INFINITY® TAA was 2%. Conclusion: Patients undergoing INFINITY® TAA had significantly lower mean AOS scores than patients undergoing ankle fusion at their last follow up after surgery, both before and after linear regression for baseline variables. This remained significant after excluding earlier (1-year) follow up, and later (9-14 year) follow up for the fusion cohort data. Modern ankle replacement designs continue to improve compared against the ankle fusion gold standard.

Orthopaedic ProceedingsVol. 107-B(SUPP_17)
Providence Health Care (CA), University of British Columbia (CA), St. Paul's Hospital (CA)
Openalex Percentile: Top 49%
Foot and Ankle Surgery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.